Zobrazeno 1 - 10
of 92
pro vyhledávání: ''
Autor:
Lash, T L1,2,3 tlash@bu.edu, Pedersen, L2, Cronin-Fenton, D2, Ahern, T P1, Rosenberg, C L3, Lunetta, K L4, Silliman, R A3, Hamilton-Dutoit, S5, Garne, J P6, Ewertz, M7, Sørensen, H T1,2, Sørensen, H T (AUTHOR)
Publikováno v:
British Journal of Cancer. 8/19/2008, Vol. 99 Issue 4, p616-621. 6p. 3 Charts.
Autor:
Nahta, R.1,2 rnahta@mdanderson.org, Esteva, F. J.1,2,3,4 festeva@mdanderson.org
Publikováno v:
Oncogene. 5/28/2007, Vol. 26 Issue 25, p3637-3643. 7p.
Publikováno v:
British Journal of Cancer. 4/10/2007, Vol. 96 Issue 7, p1025-1029. 5p. 1 Diagram, 3 Charts.
Publikováno v:
Journal of Human Genetics
Breast cancer is a heterogeneous disease that develops through a multistep process via the accumulation of genetic/epigenetic alterations in various cancer-related genes. Current treatment options for breast cancer patients include surgery, radiother
Autor:
Wells, Kristen, Pan, Tonya, Vázquez-Otero, Coralia, Ung, Danielle, Ustjanauskas, Amy, Muñoz, Dariana, Laronga, Christine, Roetzheim, Richard, Goldenstein, Marissa, Carrizosa, Claudia, Nuhaily, Sumayah, Johnson, Kenneth, Norton, Marilyn, Sims, Elizabeth, Quinn, Gwendolyn, Wells, Kristen J, Pan, Tonya M, Ustjanauskas, Amy E, Roetzheim, Richard G, Quinn, Gwendolyn P
Publikováno v:
Supportive Care in Cancer; Oct2016, Vol. 24 Issue 10, p4123-4130, 8p
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
© The Japanese Breast Cancer Society 2020
Circular RNAs are a large group of non-coding RNAs with a closed-loop structure. circRNAs play significant roles in many biological processes as miRNA sponges, regulators for gene transcription, combini
Circular RNAs are a large group of non-coding RNAs with a closed-loop structure. circRNAs play significant roles in many biological processes as miRNA sponges, regulators for gene transcription, combini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::801707b328990305344fcc66688ff574
https://hdl.handle.net/10451/49737
https://hdl.handle.net/10451/49737
Autor:
Masako Sato, Hidetoshi Kawaguchi, Satoshi Morita, Makiko Mizutani, Yoshie Hasegawa, Ken-ichi Watanabe, Yasuaki Sagara, Fumikata Hara, Takashi Morimoto, Takahiro Nakayama, Norikazu Masuda, Mitsuya Itoh, Shoichiro Ohtani, Nobuki Matsunami, Kenji Higaki, Masato Takahashi, Tetsuhiro Yoshinami
Publikováno v:
Breast Cancer (Tokyo, Japan)
Background This study aimed to investigate whether schedule modification is safe and effective in patients intolerant to the standard eribulin dose and schedule. Methods Patients with metastatic breast cancer (MBC) treated with both anthracycline and
Autor:
Cianfrocca, Mary
Publikováno v:
Current Breast Cancer Reports; Mar2012, Vol. 4 Issue 1, p83-88, 6p
Publikováno v:
European Radiology; Jul2002, Vol. 12 Issue 7, p1711-1719, 9p
Autor:
Hanne Frydenberg, Gro F. Bertheussen, Vidar Gordon Flote, Hartmut Schäfer, Inger Thune, Steinar Lundgren, Ellen Schlichting, Torfinn Støve Madssen, Erik Wist, Tone Frost Bathen, Riyas Vettukattil, Guro F. Giskeødegård, Jon Lømo, Hans E. Fjøsne
Publikováno v:
British Journal of Cancer
Background Breast cancer treatment has metabolic side effects, potentially affecting risk of cardiovascular disease (CVD) and recurrence. We aimed to compare alterations in serum metabolites and lipoproteins during treatment between recipients and no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::160be7e8db63fd6c4a60bb91080f4b51
https://hdl.handle.net/11250/2592790
https://hdl.handle.net/11250/2592790